September 14, 2019
A Study to Explore the Long-Term Safety and Efficacy of TEV-48125 (Fremanezumab) for the Prevention of Cluster Headache
Read More
January 30, 2019
A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to
Read More
January 30, 2019
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
A Study of LY2951742 in Participants With Chronic Cluster Headache
Read More
January 30, 2019
A Study of LY2951742 in Participants With Episodic Cluster Headache
Read More
January 30, 2019
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Read More
January 30, 2019
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
Read More
January 30, 2019
A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH)
Read More
January 30, 2019
Positron Emission Tomography of Infection and Vasculitis
Read More
January 30, 2019
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Read More
January 30, 2019
A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC
Read More
January 30, 2019
A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC
Read More
Load More
X